Synapsoft logo
AI Insights from Disclosures
Searching...
MYUNGIN PHARM.CO., LTD 317450
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
MYUNGIN PHARM.CO., LTD produces and sells prescription drugs, including treatments for stroke and Parkinson's disease, schizophrenia treatments, and depression treatments, based on its specialized technology in psychotropic agents (CNS: Central Nervous System) that act on the central nervous system. In particular, the company has an optimal product lineup that allows combination prescriptions for various symptoms, such as depression accompanied by sleep disorders and anxiety disorders accompanied by gastrointestinal disorders.
Representative Director Lee Gwansun,Cha Bonggwon
Founded November 8, 1988
Corporation Type KOSPI
Industry Classification Manufacture of synthetic drug and other finished medicaments
Corporate number 12431-0022866
Business number 124-81-18673
Phone Number 02-587-9060
Fax Number 02-585-0352
Company Address 361-12 Noha-gil, Paltan-myeon, Manse-gu, Hwaseong-si, Gyeonggi-do

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant